End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39,500 KRW | +6.90% | +5.33% | +243.48% |
2023 | S.Biomedics CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | S.Biomedics CO., LTD. has completed an IPO in the amount of KRW 13.5 billion. | CI |
Sales * | - | Sales 1 * | - | Capitalization | 130B 94.52M |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 | Net cash position 1 * | - 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | - |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 70.22% |
1 day | +6.90% | ||
1 week | +5.33% | ||
Current month | +5.33% | ||
1 month | +2.60% | ||
3 months | +262.05% | ||
6 months | +408.37% | ||
Current year | +243.48% |
Managers | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 18-03-28 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 19-03-30 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-03-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 18-03-28 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 19-03-30 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-03-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 39,500 | +6.90% | 726,394 |
24-06-05 | 36,950 | +0.96% | 361,563 |
24-06-04 | 36,600 | -1.08% | 340,100 |
24-06-03 | 37,000 | -1.33% | 570,579 |
24-05-31 | 37,500 | -6.95% | 468,562 |
End-of-day quote Korea S.E., June 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+243.48% | 328M | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-5.78% | 13.3B | |
-11.38% | 11.65B | |
-49.84% | 10.12B | |
+5.24% | 9.06B |
- Stock Market
- Equities
- A304360 Stock